TriageIQ™ | Universal Chronic Screener. Start Here.
Start Here.
TriageIQ™
Universal Chronic Screener
Screen. Bill. Scale.
🎉 Congratulations! TriageIQ™ has been selected for formal peer-reviewed clinical validation by NYC Research, Inc., affiliated with NYU Grossman School of Medicine and Weill Cornell School of Medicine.
Chronic Risk Screening (Adults 18+ Years)
TriageIQ™ is a proprietary, patient-administered clinical intake screener completable in approximately 1–2 minutes. Designed for adults age 18 and older—with particular clinical relevance for midlife and older adults with or at risk for chronic disease—it evaluates structured indicators across four core clinical domains: neurological, cardiometabolic, behavioral health, and pain/function signs relevant to chronic disease progression.
Informed by validated clinical frameworks and structured patient-reported indicators, TriageIQ™ intelligently triages patient needs by stratifying clinically relevant risk signals into a prioritized risk profile — helping clinicians determine which patients warrant immediate follow-up, further diagnostic evaluation, or routine monitoring. This structured approach strengthens clinical documentation, supports informed decision-making, and guides appropriate care pathways across primary and specialty care settings.
From Intake to Insight. Patients can complete TriageIQ™ screenings on-site or remotely— no special equipment required.
TriageIQ™ requires no equipment, no specialized training, and adds virtually no time to the clinical workflow. In just 1–2 minutes, the patient-administered screening produces structured, objective results and a documented clinical pathway that supports appropriate follow-up care.
TriageIQ™ can be deployed seamlessly in-clinic, remotely, through telemedicine, digital platforms, or integrated into AI voice systems. During a single screening interaction, it identifies early risk signals across four major chronic disease domains.
Neurological Risk. Silent nerve and brain changes — including cognitive decline, neuropathy, and fall risk — often appear years before symptoms. Early detection allows providers to intervene before irreversible damage occurs.
Cardiometabolic Risk. Hypertension, diabetes complications, and vascular disease frequently progress without warning. Early screening reduces the risk of heart attack, stroke, and serious complications.
Behavioral Risk. Depression, sleep disorders, and behavioral health conditions directly worsen chronic disease outcomes. Early identification enables timely support and coordinated care.
Pain/Function Risk. Chronic pain, particularly in the feet and lower extremities is a common early indicator of neurological and vascular compromise. Patient-reported pain levels establish a longitudinal baseline that supports treatment monitoring, care escalation, and ongoing clinical documentation.
TriageIQ™ applies universally across every adult patient encounter — from confirmed and suspected chronic patients to wellness visits, surgical patients, telehealth visits, CCM outreach calls, and RPM monitoring interactions.
Neurological Risks
Cardiometabolic Risks
Behavioral Risks (12+ Years)
Pain & Functional Risks
TriageIQ™ Identifies Signs for Pain/Function, Cardiometabolic, Behavioral and Neurological Risks.
Direction Before Diagnosis
Most neurological, cardiometabolic, behavioral, and pain status in chronic disease patients goes undetected until significant damage has already occurred. TriageIQ™ addresses this gap by giving providers a fast, objective, and documentable Universal Chronic Screener that identifies at-risk patients earlier, when intervention is still most effective and complications are still preventable.
Traditional screening tools are typically applied only when risk is already suspected. This selective approach overlooks a large portion of the chronic disease population because neurological, cardiometabolic, behavioral, and pain-related changes often develop silently for years before symptoms become obvious. By the time symptoms appear, meaningful damage may already be present. Waiting for symptoms is not early detection — it is late response.
TriageIQ™ was designed to become the gold standard and change that model. The screening takes just 1–2 minutes and can be embedded into routine clinical intake, telehealth visits, chronic care outreach, or other patient interactions. By applying the screener universally rather than selectively, providers gain a consistent method for identifying early risk signals across their entire chronic patient population.
🏅Built on Gold-Standard Validated Instruments—TriageIQ™ has been selected as the subject of a formal peer-reviewed QI/Real-World Evidence study conducted through NYC Research Inc., led by Dr. Anastasios Manessis, MD, FACE, ECNU, ABOM, Assistant Clinical Professor of Medicine at both NYU Grossman School of Medicine and Weill Cornell School of Medicine, further validating what providers are already experiencing in their clinical practice.
Our universal screening approach allows clinics to:
Ensure patient are not overlooked due to time constraints or assumptions
Identify early pain/function, neurological, cardiometabolic, and behavioral signals
Generate structured, audit-ready documentation for every encounter
Establish medical necessity before additional assessments
Turn routine visits into documented screening events
The clinical rationale for this approach is well supported. Research consistently shows that neurological, cardiometabolic, behavioral, and pain decline in chronic disease populations — particularly those with diabetes, cardiovascular disease, hypertension, and metabolic syndrome — often begins years before clinical symptoms appear. A universal screening model is therefore essential to detect these risks early and at the scale required for modern chronic care programs.
Alzheimer's is Underdiagnosed & Undertreated
TriageIQ™ Identifies Conditions that Support Additional Care Pathways.
Every Adult. Every Visit.*
Medicare Documentation Is Under Greater Scrutiny. Medicare documentation requirements have become significantly stricter. CMS increasingly expects providers to demonstrate a clear clinical pathway showing why neurological, cardiometabolic, behavioral, and pain-related testing was medically necessary. General observations, brief intake notes, or vague staff documentation often fail to meet this standard during audits.
When practices cannot produce structured, visit-level evidence supporting medical necessity, they face growing exposure to claim denials, recoupments, and compliance risk that can erode both revenue and reputation.
TriageIQ™ Addresses this Requirement in 1–2 Minutes
In a single interaction, TriageIQ™ generates structured documentation capturing neurological, cardiometabolic, behavioral, and pain status risk indicators. The result is a standardized record that supports clinical decision-making and demonstrates medical necessity when further evaluation is performed. Unlike informal intake processes or subjective staff observations, TriageIQ™ produces consistent, structured output that aligns with the expectations of payers, compliance reviewers, and auditors — helping close the documentation gap before it becomes a liability.
Built for Any Clinical Workflow
TriageIQ™ can be deployed through paper forms, voice agents, text links, EHR systems, or telemedicine platforms, allowing it to integrate into virtually any care environment. Primary care clinics, health systems, RPM programs, behavioral health providers, and specialty practices can implement the screening without disrupting existing workflows.
There is no lengthy implementation, no major staff retraining, and no dependency on a single technology platform. Whether a clinic operates on a legacy EHR, conducts outreach by phone, or delivers care through telemedicine, TriageIQ™ adapts to the workflow already in place.
Applied Across the Entire Adult Patient Population
TriageIQ™ is not limited to patients with established chronic disease. Most screening tools are used reactively, only after a diagnosis has already been made. TriageIQ™ is designed to be used broadly during adult patient intake, allowing providers to identify early neurological, cardiometabolic, and behavioral risk signals before conditions progress.
When risk indicators are identified, clinicians may proceed with appropriate diagnostic evaluations based on clinical judgment. Diabetes Testing Centers™ & Chronic Conditions supports providers by facilitating access to validated assessments commonly used to evaluate neurological, cardiometabolic, and behavioral conditions. By applying a consistent screening layer across patient encounters, providers can detect early chronic disease risk, strengthen clinical documentation, and guide appropriate follow-up evaluation.
*Administration of TriageIQ™ is recommended for every adult patient encounter. Billing is at the provider's discretion and should reflect clinical findings. All encounters — positive or negative — should be documented in the patient record.
Healthcare organizations, technology platforms, and provider networks interested in reviewing the full TriageIQ™ instrument may request an evaluation packet. Due to the proprietary nature of the screening methodology, detailed instrument materials are provided under mutual non-disclosure agreement.
